The landscape of dementia prognosis has advanced substantially with the appearance of innovative biomarkers, such as amyloid PET scans, tau imaging, and blood-dependent assessments that can detect Alzheimer's pathology a long time in advance of signs and symptoms emerge. When these technological advances signify amazing development in comprehending